Subscribe To
BVS / 3 Value Medical Stocks to Buy for Safety Amid Market Volatility
BVS News
By GlobeNewsWire
October 31, 2023
Bioventus to Report Third Quarter of Fiscal Year 2023 Financial Results on November 7, 2023
DURHAM, N.C., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations fo more_horizontal
By Seeking Alpha
October 11, 2023
Bioventus Stock: Improving Outlook Keeps It Interesting
Bioventus Inc. is attempting to move forward from disappointing results in recent years including the failed acquisition of "CartiHeal." The company e more_horizontal
By Zacks Investment Research
September 28, 2023
3 Value Medical Stocks to Buy for Safety Amid Market Volatility
We have narrowed our search to three value stocks from the Medical sector. These are PHG, RDNT and BVS. more_horizontal
By GlobeNewsWire
September 19, 2023
Bioventus to Present at the Cantor Global Healthcare Conference
DURHAM, N.C., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that more_horizontal
By GlobeNewsWire
September 6, 2023
Bioventus to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
DURHAM, N.C., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that more_horizontal
By PennyStocks
August 16, 2023
7 Penny Stocks To Buy According To Insiders In August
Investing in penny stocks represents an enticing prospect for those seeking to leverage the stock market's potential gains. Characterized by an inhere more_horizontal
By PennyStocks
August 15, 2023
4 Penny Stocks To Buy According To Insiders In August
Penny stocks provide a captivating opportunity for those aiming to profit in the stock market. The intrinsic risk and potential rewards associated wit more_horizontal
By Seeking Alpha
August 12, 2023
Bioventus Inc. (BVS) Q2 2023 Earnings Call Transcript
Bioventus Inc. (NASDAQ:BVS ) Q2 2023 Results Conference Call August 8, 2023 8:30 AM ET Company Participants Dave Crawford - VP, IR Tony Bihl - CEO Mar more_horizontal